The Costs of Industry-Sponsored Drug Trials in Canada.

ABSTRACT:

Objective

The objective of this study was to estimate the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada.

Methods

We used the Aggregate Analysis of ClinicalTrials.gov (AACT) database, and included all industry-sponsored drug CTs that were conducted in Canada and completed in 2016. We estimated the costs of the study drugs using the market price. Estimates of the costs of management and patient services were based on industry contracts.

Results

The sample included 394 CTs that were conducted in 2039 facilities in Canada and provided services for 20,126 Canadian enrollees. Two-thirds of the CTs (277 of 394) were in the non-cancer category. On average, the drug costs per patient were 89,680 Canadian dollars ($Can) during the li

SUBMITTER: Tran DT 

PROVIDER: S-EPMC7248139 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature